Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Insights on the Global Heparin Market 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 - Technavio


NEW YORK, March 3, 2021 /PRNewswire/ --The heparin market is expected to grow by USD 941.2 mn, progressing at a CAGR of almost 3% during the forecast period. Get Free Sample Report in MINUTES

The increasing prevalence of chronic conditions is one of the major factors propelling market growth.

More details: https://www.technavio.com/report/heparin-market-industry-analysis

Heparin Market: Route of administration Landscape

Based on the product, the subcutaneous injection segment is expected to witness lucrative growth during the forecast period.

Heparin Market: Geographic Landscape

By geography, Europe is going to have a lucrative growth during the forecast period. About 23% of the market's overall growth is expected to originate from Europe. Germany and the UK are the key markets for heparin in Europe.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Related Reports on Health Care Include:


Companies Covered:

What our reports offer:

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

PART 07: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

PART 15: APPENDIX

PART 16: EXPLORE TECHNAVIO

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report Page:https://www.technavio.com/report/heparin-market-industry-analysis

SOURCE Technavio


These press releases may also interest you

at 08:00
"AI has no greater purpose than improving the health of everyone," says CEO John Fraser. Every day, one billion people turn to Google to inquire about their health concerns. Treatment.com saw the opportunity to provide more accurate results backed...

at 07:55
Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced its Interactive Response Technology (IRT) solution has reached a significant milestone....

at 07:45
The "Global Regenerative Medicines Market 2020-2030: Focus on Products, Applications, 17 Countries' Data and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. The global regenerative medicines market is projected to...

at 07:45
CalAmp® , a connected intelligence company that helps people and businesses work smarter, today unveiled its new SC1302tm single-use smart tracking device that can monitor temperatures as low as -20 degrees Celsius. The smart device provides granular...

at 07:41
January ? March Revenues amounted to MSEK 713.0 (793.6), corresponding to a decrease of -10% for the period.  Revenues amounted to MSEK 713.0 ( 793.6), corresponding to a decrease of -10% for the period. The organic growth* during the first quarter...

at 07:35
Organicell Regenerative Medicine, Inc. , a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...



News published on 3 march 2021 at 18:00 and distributed by: